What is he best known for?
The fields of study he is best known for:
His main research concerns Antigen, Molecular biology, Monoclonal antibody, Antibody and Immunology.
His Antigen study combines topics in areas such as Immune system, Immunotherapy, Pathology, Melanoma and Ganglioside.
His Molecular biology research is multidisciplinary, incorporating perspectives in Cytotoxic T cell, Cell, Melanotransferrin and Peptide sequence.
Karl Erik Hellström has researched Monoclonal antibody in several fields, including In vitro, Cytotoxicity, Biochemistry and Ricin.
His In vitro research includes elements of Lymph node and Transplantation.
His Immunology research integrates issues from Neuroblastoma cell and Neoplasm Transplantation.
His most cited work include:
- Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 (1026 citations)
- Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors (835 citations)
- Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. (654 citations)
What are the main themes of his work throughout his whole career to date?
Karl Erik Hellström mostly deals with Antigen, Molecular biology, Immunology, Antibody and Monoclonal antibody.
The various areas that Karl Erik Hellström examines in his Antigen study include In vitro, Neoplasm, Pathology, Melanoma and Immunotherapy.
As a member of one scientific family, Karl Erik Hellström mostly works in the field of Molecular biology, focusing on Cytotoxic T cell and, on occasion, Virology.
His Antibody study frequently draws connections between related disciplines such as Internal medicine.
His work on Pan-T antigens is typically connected to Conjugate as part of general Monoclonal antibody study, connecting several disciplines of science.
His studies in Immune system integrate themes in fields like Cancer research and Transfection.
He most often published in these fields:
- Antigen (63.25%)
- Molecular biology (46.99%)
- Immunology (45.18%)
What were the highlights of his more recent work (between 1996-2020)?
- Immunology (45.18%)
- Immune system (25.00%)
- Antibody (39.16%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Immunology, Immune system, Antibody, Cancer research and Monoclonal antibody.
In his research on the topic of Immunology, Clone is strongly related with Melanoma.
His Antibody research includes themes of Cancer, Clinical efficacy, Tumor cells and Pathology.
His Monoclonal antibody research includes elements of Molecular biology, In vitro, Biochemistry and Doxorubicin.
He has included themes like Tumor necrosis factor alpha, Transplantation and Antigen in his Immunotherapy study.
Antigen and Carcinoma are frequently intertwined in his study.
Between 1996 and 2020, his most popular works were:
- Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors (835 citations)
- AMPLIFICATION OF TUMOR IMMUNITY BY GENE TRANSFER OF THE CO-STIMULATORY 4-1BB LIGAND : SYNERGY WITH THE CD28 CO-STIMULATORY PATHWAY (216 citations)
- Cutting edge: CD83 regulates the development of cellular immunity. (129 citations)
In his most recent research, the most cited papers focused on:
Karl Erik Hellström spends much of his time researching Monoclonal antibody, Cytotoxic T cell, Doxorubicin, Immunology and Pathology.
His Monoclonal antibody study combines topics in areas such as CD8 and Antigen.
His CD8 study which covers Immunotherapy that intersects with Molecular biology.
Within one scientific family, he focuses on topics pertaining to T cell under Cytotoxic T cell, and may sometimes address concerns connected to Interleukin 12 and Cell biology.
As part of the same scientific family, Karl Erik Hellström usually focuses on Immunology, concentrating on Cancer research and intersecting with Antigen-presenting cell.
His Pathology study incorporates themes from Cancer, Urine, Creatinine, Antibody and Receiver operating characteristic.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
